We are live on ! Find out more
AFIB

Acutus Medical Inc

Delisted

AFIB was delisted on the 8th of May, 2024.

29 hedge funds and large institutions have $1.41M invested in Acutus Medical Inc in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

3% less funds holding

Funds holding: 3029 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

76% less capital invested

Capital invested by funds: $5.98M → $1.41M (-$4.57M)

Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
7
Reduced
4
Closed
7
Calls
Puts
Net Calls
Net Calls Change

AFIB Hedge Fund Activity: Q4 2023 in Review

29 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Acutus Medical Inc (AFIB) for Q4 2023, worth a combined $1.41M — down 76% from $5.98M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of AFIB and 6 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 7 added.

The largest buyer was HRT Financial, opening a new position worth an estimated $46.2K. The largest seller was Parkman Healthcare Partners, exiting entirely with an estimated $553K sold.

  • 29 institutional investors held Acutus Medical Inc (AFIB) as of Q4 2023, down from 30 in Q3 2023.
  • Funds reported $1.41M of Acutus Medical Inc stock for Q4 2023, down 76% quarter-over-quarter.
  • 6 funds opened new Acutus Medical Inc positions in Q4 2023 and 7 closed out, a net change of -1 holder.
  • The largest Acutus Medical Inc buyer in Q4 2023 was HRT Financial, an estimated $46.2K added.
  • The largest Acutus Medical Inc seller in Q4 2023 was Parkman Healthcare Partners, an estimated $553K sold.

Based on aggregated 13F filings for Q4 2023.